Back
Open Access

Additional benefits ofSGLT2i therapy in patients with acute decompensated heart failure and central sleep apnea.

Session: Improving outcomes in acute heart failure
Topic: Pharmacotherapy
Speaker: Assistant Professor P. Kalaydzhiev (Sofia, BG)
Event: ESC Acute CardioVascular Care 2025

Congress Presentation

Add to my library

Like

About the speaker

Assistant Professor Petar Kalaydzhiev

University Hospital Tsaritsa Yoanna, Sofia (Bulgaria)
0 follower

8 more presentations in this session

Clinical determinants and long-term survival in heart failure with supra-normal ejection fraction. Insights from LECRA-HF registry.

Speaker: Doctor K. Stepien (Krakow, PL)

Access
Abstract
Like
Thumbnail

Early predictors of in-hospital mortality in patients with acute heart failure. A general hospital experience

Speaker: Doctor G. Aletras (Heraklion, GR)

Access
Abstract
Like
Thumbnail

Predictors of mortality in heart failure patients with reduced ejection fraction: neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, neutrophil- percentage-to-albumin-ratio

Speaker: Doctor J. Stevic (Belgrade, RS)

Access
Abstract
Like
Thumbnail

Genetic insights into cardiomyopathy: familial and histologic features of transplant-dependent failing hearts in hcmp

Speaker: Doctor K. Kim (Incheon, KR)

Access
Abstract
Like
Thumbnail

Current practices and perspectives on the use of intravenous vasodilators in acute heart failure: an international survey.

Speaker: Doctor A. Galluzzo (Rivoli, IT)

Access
Abstract
Like
Thumbnail

Access the full session

Improving outcomes in acute heart failure

Speakers: Assistant Professor P. Kalaydzhiev, Doctor K. Stepien, Doctor G. Aletras, Doctor J. Stevic, Doctor K. Kim...
Access
Like
Thumbnail

About the event

Image

ESC Acute CardioVascular Care 2025

14 March - 15 March 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources